Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin)

Product Sizes
100 ug
£635.00
CHB263-100UG
1 mg
£2295.00
CHB263-1MG
About this Product
SKU:
CHB263
Additional Names:
IgG1|lifastuzumab vedotin
Application:
Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
Buffer:
25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Clonality:
Recombinant Monoclonal
Concentration:
1 mg/ml
Extra Details:
Lifastuzumab vedotin is an ADC consisting of a NaPi2b-directed antibody and Monomethyl auristatin E (MMAE) used for the study of non-small cell lung cancer.
Formulation:
25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Immunogen:
NaPi2b / SLC34A2
Isotype:
IgG1
Physical State:
Lyophilized
Purity:
>90%
Reactivities:
Human
Shipping Conditions:
Blue Ice
Specificity:
NaPi2b / SLC34A2
Storage Conditions:
-70[o]C Avoid freeze/thaw cycles., 2-8[o]C
Supplier:
Sanyou Biopharmaceuticals
Type:
Antibody: Biosimilar Antibody
  • Manufacturer's Data Sheet:CHB263
Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin) is more than 95%, determined by SEC-HPLC.
The drug-to-antibody ratio (DAR) of the Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin) is 3.7.
Human NaPi2b CHO-S Cells were stained with Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
Human NaPi2b HEK293 Cell Line were stained with Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin)and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 0.9793 ug/mL.